Medication approved by the Food and Drug Administration (FDA) called Azstarys is used to treat some symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in patients aged 6 and older… Read More

Azstarys, a drug available in the market, contains serdexmethylphenidate and dexmethylphenidate as a combined fixed dose. This medication is primarily used to treat those who suffer from att… Read More

Zevra Therapeutics (NASDAQ:ZVRA) announced today that it will begin trading under the new ticker symbol “ZVRA” on the Nasdaq Global Select Market as of March 1, 2023. The rare di… Read More

Attention Deficit Hyperactivity Disorder (ADHD)How Long Does Medication Treatment for ADHD Last?22nd Dec 2022… Read More

Enchancment in sleep area scores was statistically important and noticed all through the twelve-month examine. New information exhibits that kids with attention-deficit hyperactivity dysfun… Read More

After a big year for the pharmaceutical company, KMPH stock is still down over 15% so far in 2021. Not only that, but KemPharm (NASDAQ: KMPH) is down significantly from last year after issui… Read More

KP879, KemPharm’s Lead Product Candidate Based on SDX and Intended for the Treatment of Stimulant Use Disorder (SUD), Could Be Schedule IV, If Approved by the FDA CELEBRATION, Fla… Read More